AGILE THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Agile Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2014 to Q2 2024.
  • Agile Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 6.86M shares, a 287% increase year-over-year.
  • Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.16M shares, a 399% increase from 2022.
  • Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 432K shares, a 791% increase from 2021.
  • Agile Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 48.5K shares, a 97.7% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 6.86M +5.09M +287% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 4.63M +3.72M +408% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.16M +1.72M +399% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 2.95M +2.21M +299% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.77M +1.68M +1862% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 912K +850K +1364% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 432K +384K +791% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 740K -1.6M -68.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 90.2K -2.13M -95.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 62.3K -2.13M -97.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 48.5K Oct 1, 2021 Dec 31, 2021 10-K 2024-03-28
Q3 2021 2.34M -85M -97.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 2.22M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 2.19M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 87.4M Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-30
Q1 2015 21.3M +20.5M +2489% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-12
Q1 2014 822K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.